{"date":"2025-10-03","count":6,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4771-2025-10-03-1941-16g7qjx","company_id":"4771","company":"望隼","market":"上市","industry":"生技醫療","date":"2025-10-03","time":"19:41:36","subject":"公告本公司初次申請股票上市時所出具之承諾事項暨其後續執行情形","clause":"第51款","fact_date":"2025-10-03","cite_as":"公開資訊觀測站重大訊息：望隼（4771），2025-10-03 19:41，「公告本公司初次申請股票上市時所出具之承諾事項暨其後續執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2025-10-03-1755-1jyo007","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2025-10-03","time":"17:55:11","subject":"公告本公司股票改列上市前現金增資發行新股相關事宜(確定承銷價格)","clause":"第11款","fact_date":"2025-10-03","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2025-10-03 17:55，「公告本公司股票改列上市前現金增資發行新股相關事宜(確定承銷價格)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-10-03-1719-1qjk5w7","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-10-03","time":"17:19:54","subject":"公告本公司今日接獲註冊代理人通知，墨西哥衛生部(COFEPRIS)受理Bonvadis外用乳膏完全傷口適應症醫材產品註冊申請","clause":"第10款","fact_date":"2025-10-03","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-10-03 17:19，「公告本公司今日接獲註冊代理人通知，墨西哥衛生部(COFEPRIS)受理Bonvadis外用乳膏完全傷口適應症醫材產品註冊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-10-03-1703-15fjys7","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-10-03","time":"17:03:14","subject":"公告本公司今日接獲註冊代理人通知，泰國食品藥物監督管理局(ThaiFDA)受理Bonvadis外用乳膏完全傷口適應症產品註冊申請","clause":"第10款","fact_date":"2025-10-03","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-10-03 17:03，「公告本公司今日接獲註冊代理人通知，泰國食品藥物監督管理局(ThaiFDA)受理Bonvadis外用乳膏完全傷口適應症產品」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-10-03-1610-o9jske","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-10-03","time":"16:10:28","subject":"公告本公司申請股票上巿時所出具之承諾事項暨其後續執行情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-10-03 16:10，「公告本公司申請股票上巿時所出具之承諾事項暨其後續執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-10-03-1605-g5o5zl","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-10-03","time":"16:05:38","subject":"公告本公司114年現金增資認股基準日相關事宜","clause":"第11款","fact_date":"2025-10-03","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-10-03 16:05，「公告本公司114年現金增資認股基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}